Dopamine overdose hypothesis: evidence and clinical implications.
about
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's DiseaseThe neurobiological basis of cognitive impairment in Parkinson's disease.Behavioral effects of levodopa.Plant phenolics are detoxified by prophenoloxidase in the insect gut.Cognitive Contributions to Freezing of Gait in Parkinson Disease: Implications for Physical Rehabilitation.Parkinson's disease and the Stroop color word test: processing speed and interference algorithms.Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers.Dopaminergic modulation of performance monitoring in Parkinson's disease: An event-related potential study.The highs and lows of beta activity in cortico-basal ganglia loops.Does response inhibition have pre- and postdiagnostic utility in Parkinson's disease?Implicit Motor Sequence Learning in Individuals with Parkinson Disease: A Meta-Analysis.Therapy-resistant symptoms in Parkinson's disease.Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.Dopamine Gene Profiling to Predict Impulse Control and Effects of Dopamine Agonist Ropinirole.Distinct alterations in Parkinson's medication-state and disease-state connectivityThe Effect of Levodopa on Improvements in Protective Stepping in People With Parkinson's Disease.Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson's Disease.Dopaminergic polymorphisms associated with medication responsiveness of gait in Parkinson's disease.Motivation-cognition interaction: how feedback processing changes in healthy ageing and in Parkinson's disease.Neurological and Neuropsychological Problems in Tyrosinemia Type I Patients.The dark side of dopaminergic therapies in Parkinson's disease: shedding light on aberrant salience.Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson's Disease.Parkinson's disease psychosis as a serotonin-dopamine imbalance syndrome.The effect of dopaminergic medication on conflict adaptation in Parkinson's disease.Training for Micrographia Alters Neural Connectivity in Parkinson's Disease.Perceptual Decisions Based on Previously Learned Information are Independent of Dopaminergic Tone.Positron emission tomography in Parkinson's disease: insights into impulsivity.Mechanism of action of pimavanserin in Parkinson's disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors.The Intersection of Central Dopamine System and Stroke: Potential Avenues Aiming at Enhancement of Motor Recovery
P2860
Q27002626-BB6F48FB-6ADB-4D9B-A6BD-77AE2D53D5AAQ27327538-4E49CA94-A7B7-4403-89AA-8889D443AA02Q33724698-875E5024-8C78-4D37-870B-EF7941E63608Q34452922-5655BFC4-85C5-4DDD-B6AF-3D8303EF3F8EQ36305566-BAC325B0-0164-4FBA-B928-CCD0D15A1B0EQ36875142-039251BE-3FF9-4ECA-897D-D9D470B4183CQ37284376-F6BDA8FE-4E61-4C85-B532-49FC328D3351Q37345319-F5A2D7A1-8D8D-4FD8-99C3-8922176E0025Q37602022-E45ABD7A-B326-46BB-82BD-15CF76EC1E2BQ38217078-9DE08CB3-0078-4F68-B303-4B7C3C8D041DQ38313013-91E56EFF-8E52-45C9-AF2A-B306F09742DEQ38592732-DD0D595C-05BE-4512-8BA6-0B8ED58F5E56Q38593798-4372D4B3-E2F6-4002-8E29-FA7F4FABFF84Q38712774-87DA0617-32C4-48AC-B7BE-550B9E226841Q39136481-7CCBF860-AE80-4567-A7F9-92D0E452701EQ42159804-988BE44C-895F-4412-A077-5847E594B08CQ42646983-1E1828AD-B928-4FAB-9DF3-1BDE0E4D8A61Q42696309-F2F2C7F7-0930-4980-B895-B584DD015851Q47295021-E40208A1-34BC-44F5-A1AD-9C4C804207DFQ47662347-36127EDA-4C65-4554-83DC-E4D5172977B0Q47762401-34CB79E2-A8BB-4407-A087-AD18B97313B7Q47783978-1541996B-3AAB-4A11-90C8-A9597CC45A29Q47849289-A78ABD97-27CA-4DD9-AB7F-C5E721545293Q48492369-EA84E1FA-9AFD-48BD-A43B-71A889B74E49Q49078823-86233C5C-A0C9-4DD6-85C4-A19BE61DCCDAQ49355729-2BEFCEE7-6A34-4CE6-9B56-BCF7650969A1Q49788001-572507FD-B134-4569-9B75-AC954C1A57E9Q50069106-2EB3B881-5D6E-4B64-84F3-3F73FE9274D3Q51583546-A4A7F4DD-83D3-4609-A902-A370BF3B0648Q57176938-0C8E658A-9DA7-4B18-9D8F-61EFF4B11E43
P2860
Dopamine overdose hypothesis: evidence and clinical implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dopamine overdose hypothesis: evidence and clinical implications.
@en
Dopamine overdose hypothesis: evidence and clinical implications.
@nl
type
label
Dopamine overdose hypothesis: evidence and clinical implications.
@en
Dopamine overdose hypothesis: evidence and clinical implications.
@nl
prefLabel
Dopamine overdose hypothesis: evidence and clinical implications.
@en
Dopamine overdose hypothesis: evidence and clinical implications.
@nl
P2093
P2860
P356
P1433
P1476
Dopamine overdose hypothesis: evidence and clinical implications.
@en
P2093
Daniel Schonfeld
David E Vaillancourt
Rachael Seidler
Youngbin Kwak
P2860
P304
P356
10.1002/MDS.25687
P407
P577
2013-10-09T00:00:00Z